Altimmune ALT Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Altimmune’s reported figures.
Based on trailing twelve months.
The official record: Altimmune’s 10-K, filed March 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's free cash flow margin?
- Altimmune (ALT) reported free cash flow margin of -17,806.8% in Q4 2023.
- How has Altimmune's free cash flow margin changed year-over-year?
- Altimmune's free cash flow margin decreased by 119.3% year-over-year, from 92,223.5% to -17,806.8%.
- What is the long-term trend for Altimmune's free cash flow margin?
- Over 3 years (2020 to 2023), Altimmune's free cash flow margin has grown at a 248.2% compound annual growth rate (CAGR), from -421.6% to -17,806.8%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.